Jun 17, 2008: Forbes Medi-Tech Achieves "Minimum Bid Price Requirement" for Continue... read more »

Jun 09, 2008: Forbes Medi-Tech Receives Extension to Achieve Nasdaq's "Minimum Bid P... read more »

May 15, 2008
Webcast/Conference Call: Corporate Update/First Quarter Results   more »

April 18, 2008
"A natural way to lower cholesterol" - King 5 News Report  more »

Digital Media section »

The strategy and vision of Forbes Medi-Tech Inc. is to develop and market a portfolio of nutraceutical products, including functional foods and dietary supplements, for the benefit of all consumers. An increasingly active population, the pursuit of healthier lifestyles and the desire to live longer have given rise to a category of products known as nutraceuticals. This category includes functional foods, which are conventional foods containing ingredients that provide additional health or nutritional benefits leading to possible risk reduction of contracting chronic diseases.

Forbes Medi-Tech is listed on the Toronto Stock Exchange under the symbol FMI and on NASDAQ under FMTI.

On May 15th, Forbes announced plans to realign our business to focus on the business areas which are generating immediate revenue. This strategic focus on the nutraceutical sector represents a truly pivotal point in Forbes' development. To address these growing market opportunities within functional foods and dietary supplements, Forbes has developed Reducol™, a branded, non-GMO, clinically proven ingredient that helps lower LDL (bad) cholesterol safely and naturally. Reducol™ has been successfully launched in more than 10 countries worldwide with continued expansion underway ... Get more info on Reducol